Kew M C
Medical Research Council/University Molecular Hepatology Research Unit, Johannesburg and Baragwanath Hospitals, South Africa.
Princess Takamatsu Symp. 1995;25:33-40.
Chronic hepatitis C virus (HCV) infection is implicated in the etiology and pathogenesis of a relatively small proportion of hepatocellular carcinomas (HCC) in black residents of southern Africa. The major risk factor for the tumor in this population is chronic hepatitis B virus (HBV) infection acquired early in life. Only 13.2% of black patients with HCC are currently infected with HCV (as judged by the presence of HCV RNA in serum) alone, and another 4.3% are infected with both HCV and HBV. Antibody to HCV can be detected with second generation assays in 19.5% of HCC patients. Fifty percent of the HCC patients have only current HBV infection and a further 35.9% show markers of past HBV infection (including 9.1% who also are currently infected with HCV). The prevalence of current HBV infection is significantly lower in HCV RNA-positive than in HCV RNA-negative patients, and this difference is independent of the sex, age, or geographical location of the patients. Only 5.4% of HCC patients are not infected with either HBV or HCV. Patients with HCV-associated HCC are appreciably older than those with tumors not associated with HCV and those with tumors associated with HBV, and the differences are independent of geographical location of the patients. Patients with HCV-associated HCC are more likely to be urban dwellers and less likely to be rural dwellers than are those with HBV-related tumors. Differences in sex distribution and alpha-fetoprotein levels just fail to reach statistical significance between patients with HCV-related and HBV-related HCC. The pathogenesis of HCV-related HCC in black Africans, as in all populations, is uncertain. A direct carcinogenic effect appears unlikely, and the available evidence favors an indirect effect mediated via chronic necroinflammatory hepatic disease. Because very few of our patients undergo surgery or have a necropsy performed, the relationship between HCV-associated HCC and cirrhosis in black Africans has not been analyzed.
慢性丙型肝炎病毒(HCV)感染与非洲南部黑人居民中相对较小比例的肝细胞癌(HCC)的病因和发病机制有关。该人群中肿瘤的主要危险因素是早年感染的慢性乙型肝炎病毒(HBV)。目前,仅13.2%的黑人HCC患者单独感染HCV(根据血清中HCV RNA的存在判断),另有4.3%同时感染HCV和HBV。采用第二代检测方法可在19.5%的HCC患者中检测到抗HCV抗体。50%的HCC患者仅目前感染HBV,另有35.9%显示既往HBV感染的标志物(包括9.1%目前也感染HCV的患者)。HCV RNA阳性患者中目前HBV感染的患病率显著低于HCV RNA阴性患者,且这种差异与患者的性别、年龄或地理位置无关。仅5.4%的HCC患者未感染HBV或HCV。与HCV相关的HCC患者明显比与HCV无关的肿瘤患者以及与HBV相关的肿瘤患者年龄更大,且这些差异与患者的地理位置无关。与HBV相关肿瘤患者相比,与HCV相关的HCC患者更可能是城市居民,而农村居民的可能性较小。HCV相关和HBV相关HCC患者之间的性别分布和甲胎蛋白水平差异仅未达到统计学意义。与所有人群一样,非洲黑人中与HCV相关的HCC的发病机制尚不确定。直接致癌作用似乎不太可能,现有证据支持通过慢性坏死性炎症性肝病介导的间接作用。由于我们的患者中很少有人接受手术或进行尸检,因此尚未分析非洲黑人中与HCV相关的HCC与肝硬化之间的关系。